甲磺酸伊马替尼市场分析

Market Analysis of Imatinib mesylate

介绍了近年来甲磺酸伊马替尼的注册和市场发展现状,分析了其在中国的上市信息和中国注册厂家的数据、销售情况,得出该商品市场潜力巨大,有十几家以上科研企业。近6年其全球销售增长率在40%以上,近7年在替尼类市场占有率提升至20%以上。提出未来该产品市场空间较大,已引起众多制药企业的青睐。

The Chinese registration and global marketing conditions of imatinib mesylate were indroduced in recent years.Through analyzing the listed market information and the global marketing data,the results were that the data of Chinese registered manufactures and the drugs had big marketing,and there were more than a dozen research enterprises,the growth rate was up 40% in recent six years,the market share of imatinib class increased to 21.27% in recent seven years.It was pointed out that the drug had a market prospect,and many pharmaceutical enterprises paid attention to it.